JW Pharmaceutical Corporation (KRX:001060)

JW Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	729,685	584,933	561,695	828,523	419,688	505,678
Market Cap Growth	34.57%	4.14%	-32.20%	97.41%	-17.00%	-32.85%
Enterprise Value	722,979	571,085	600,784	959,912	491,395	649,827
Last Close Price	31950.00	25500.00	24000.00	34877.84	17456.16	20654.29
PE Ratio	12.61	9.51	8.64	22.39	13.16	-
PS Ratio	0.94	0.75	0.78	1.11	0.61	0.83
PB Ratio	1.98	1.58	1.71	3.12	1.86	2.68
P/TBV Ratio	2.05	1.64	1.76	3.29	1.84	2.68
P/FCF Ratio	8.62	6.91	7.90	13.84	8.96	47.45
P/OCF Ratio	7.57	6.07	7.08	9.51	7.39	27.90
EV/Sales Ratio	0.93	0.74	0.84	1.28	0.72	1.07
EV/EBITDA Ratio	6.64	5.36	5.90	8.05	6.36	13.84
EV/EBIT Ratio	8.02	6.50	7.26	9.93	8.12	21.07
EV/FCF Ratio	8.54	6.75	8.45	16.03	10.49	60.98
Debt / Equity Ratio	0.15	0.15	0.28	0.64	0.93	1.30
Debt / EBITDA Ratio	0.51	0.51	0.90	1.43	2.71	5.22
Debt / FCF Ratio	0.65	0.65	1.29	2.84	4.47	23.00
Net Debt / Equity Ratio	-0.02	-0.02	0.18	0.29	0.27	0.95
Net Debt / EBITDA Ratio	-0.06	-0.06	0.58	0.64	0.77	3.82
Net Debt / FCF Ratio	-0.08	-0.08	0.83	1.27	1.28	16.84
Asset Turnover	1.28	1.28	1.15	1.18	1.09	1.03
Inventory Turnover	3.75	3.75	3.64	3.79	3.70	3.65
Quick Ratio	0.86	0.86	0.82	0.90	0.80	0.79
Current Ratio	1.42	1.42	1.47	1.32	1.12	1.30
Return on Equity (ROE)	17.60%	17.60%	21.87%	15.65%	14.41%	-0.73%
Return on Assets (ROA)	9.08%	9.08%	8.28%	9.49%	6.00%	3.26%
Return on Invested Capital (ROIC)	17.31%	16.20%	17.88%	21.60%	12.18%	-0.62%
Return on Capital Employed (ROCE)	22.20%	22.20%	20.90%	27.00%	24.40%	8.80%
Earnings Yield	8.43%	10.52%	11.58%	4.47%	7.60%	-0.19%
FCF Yield	11.60%	14.47%	12.65%	7.23%	11.16%	2.11%
Payout Ratio	17.99%	17.99%	14.86%	23.82%	23.05%	-
Buyback Yield / Dilution	1.32%	1.32%	-3.34%	-2.49%	-0.07%	0.05%
Total Shareholder Return	2.77%	1.32%	-3.34%	-2.49%	-0.07%	0.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.